Literature DB >> 16787760

Antibodies from patients with dengue viral infection mediate cellular cytotoxicity.

G García1, M Arango, A B Pérez, L Fonte, B Sierra, R Rodríguez-Roche, E Aguirre, I Fiterre, M G Guzmán.   

Abstract

Acute and late convalescent sera (collected at day 5 of disease onset and 1 year later) from dengue fever (DF) and dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) laboratory confirmed cases, were tested for antibody-dependent cell-mediated cytotoxicity (ADCC) activity using dengue 1 (DENV-1) or dengue 2 (DENV-2) infected cells as target. All patients experienced their first dengue virus (DENV) infection 20 years before. ADCC activity was detected in acute sera from DHF/DSS but not in sera from DF patients. However, 1 year after illness, ADCC activity was observed in all cases. This preliminary report represents one of the few studies of ADCC in dengue patients and suggests that ADCC could be implicated in dengue pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16787760     DOI: 10.1016/j.jcv.2006.04.010

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  15 in total

Review 1.  Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Authors:  Anuja Mathew; Elizabeth Townsley; Francis A Ennis
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

Review 2.  Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms.

Authors:  Alan L Rothman
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

Review 3.  Dengue: knowledge gaps, unmet needs, and research priorities.

Authors:  Leah C Katzelnick; Josefina Coloma; Eva Harris
Journal:  Lancet Infect Dis       Date:  2017-02-07       Impact factor: 25.071

4.  Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity.

Authors:  Matthew Dent; Jonathan Hurtado; Amber M Paul; Haiyan Sun; Huafang Lai; Ming Yang; Adrian Esqueda; Fengwei Bai; Herta Steinkellner; Qiang Chen
Journal:  J Gen Virol       Date:  2016-10-20       Impact factor: 3.891

Review 5.  Development of plant-made monoclonal antibodies against viral infections.

Authors:  Qiang Chen
Journal:  Curr Opin Virol       Date:  2021-12-18       Impact factor: 7.090

6.  Impact of viral attachment factor expression on antibody-mediated neutralization of flaviviruses.

Authors:  Christopher J Obara; Kimberly A Dowd; Julie E Ledgerwood; Theodore C Pierson
Journal:  Virology       Date:  2013-01-10       Impact factor: 3.616

7.  Therapeutic efficacy of humanized monoclonal antibodies targeting dengue virus nonstructural protein 1 in the mouse model.

Authors:  Sen-Mao Tien; Po-Chun Chang; Yen-Chung Lai; Yung-Chun Chuang; Chin-Kai Tseng; Yu-San Kao; Hong-Jyun Huang; Yu-Peng Hsiao; Yi-Ling Liu; Hsing-Han Lin; Chien-Chou Chu; Miao-Huei Cheng; Tzong-Shiann Ho; Chih-Peng Chang; Shu-Fen Ko; Che-Piao Shen; Robert Anderson; Yee-Shin Lin; Shu-Wen Wan; Trai-Ming Yeh
Journal:  PLoS Pathog       Date:  2022-04-29       Impact factor: 6.823

Review 8.  Control of acute dengue virus infection by natural killer cells.

Authors:  Caroline Petitdemange; Nadia Wauquier; Juliana Rey; Baptiste Hervier; Eric Leroy; Vincent Vieillard
Journal:  Front Immunol       Date:  2014-05-13       Impact factor: 7.561

9.  Dengue Virus Induces NK Cell Activation through TRAIL Expression during Infection.

Authors:  Mariana Gandini; Fabienne Petitinga-Paiva; Cíntia Ferreira Marinho; Gladys Correa; Luzia Maria De Oliveira-Pinto; Luiz José de Souza; Rivaldo Venâncio Cunha; Claire Fernandes Kubelka; Elzinandes Leal de Azeredo
Journal:  Mediators Inflamm       Date:  2017-09-05       Impact factor: 4.711

10.  The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.

Authors:  Laura A VanBlargan; Swati Mukherjee; Kimberly A Dowd; Anna P Durbin; Stephen S Whitehead; Theodore C Pierson
Journal:  PLoS Pathog       Date:  2013-12-05       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.